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Abstract	
A	method	for	accessing	the	formally	14	VE	iridium(III)	hydride	fragment	{Ir(IBioxMe4)2(H)2}+	2	containing	the	
conformationally	rigid	NHC	ligand	IBioxMe4	 is	reported.	Hydrogenation	of	trans-[Ir(IBioxMe4)2(COE)Cl]	1	 in	
the	 presence	 of	 excess	 Na[BArF4]	 leads	 to	 formation	 of	 dimeric	 [{Ir(IBioxMe4)2(H)2}2Cl][BArF4]	 3,	 which	 is	
structurally	fluxional	in	solution	and	acts	as	a	reservoir	of	monomeric	2	 in	the	presence	of	excess	halogen	
ion	 abstractor.	 Stable	 dihydride	 complexes	 trans-[Ir(IBioxMe4)2(2,2’-bipyridine)(H)2][BArF4]	 4	 and	
[Ir(IBioxMe4)3(H)2][BArF4]	5	were	 subsequently	 isolated	 through	 in	 situ	 trapping	 of	2	 using	 2,2’-bipyridine	
and	IBioxMe4,	respectively,	and	fully	characterised.	Using	mixtures	of	3	and	Na[BArF4]	as	a	latent	source	of	
2,	 the	 reactive	monomeric	 fragment’s	 reactivity	was	explored	with	excess	ethylene	and	cyclooctene,	and	
trans-[Ir(IBioxMe4)2(C2H4)2][BArF4]	 6	 and	 cis-[Ir(IBioxMe4)2(COD)][BArF4]	 7	 were	 isolated,	 respectively,	
through	sacrificial	hydrogenation	of	the	alkenes.	Complex	6	 is	notable	for	the	adoption	of	a	very	unusual	
orthogonal	 arrangement	 of	 the	 trans-ethylene	 ligands	 in	 the	 solid-state,	 which	 has	 been	 analysed	
computationally	 using	 energy	 and	 charge	 decomposition	 (EDA-NOCV).	 The	 formation	 of	 7	 via	 transfer	
dehydrogenation	of	COE	highlights	the	ability	to	partner	IBioxMe4	with	reactive	metal	centres	capable	of	C–
H	 bond	 activation,	 without	 intramolecular	 activation.	 Reaction	 of	 7	 with	 CO	 slowly	 formed	 trans-
[Ir(IBioxMe4)2(CO)2][BArF4]	 8,	 but	 the	 equivalent	 reaction	 with	 bis-ethylene	 complex	 6	 was	 an	 order	 of	
magnitude	faster,	quantifying	the	strong	coordination	of	COD	in	7.	 	
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Introduction	
Bioxazoline-derived	 imidazol-2-ylidene	 ligands	 (IBiox)	 developed	 by	 Glorius	 and	 co-workers	 are	 N-
heterocyclic	carbenes	(NHCs)	with	considerable	potential	for	organometallic	chemistry	and	catalysis	(Chart	
1)	–	the	readily	adapted	bioxazoline	backbone	provides	a	versatile	scaffold	for	the	synthesis	of	achiral	and	
chiral	 ligands	 with	 tuneable	 steric	 bulk.1	 However,	 despite	 finding	 notable	 application	 in	 palladium-
catalysed	 cross-coupling	 reactions,	 the	 coordination	 chemistry	 of	 IBiox	 ligands	 has	 remained	 largely	
unexplored.	With	the	aim	of	investigating	low-coordinate	NHC	complexes	of	rhodium	and	iridium,	we	have	
recently	 begun	 to	 expand	 the	 coordination	 chemistry	 of	 IBiox	 ligands,	 seeking	 to	 exploit	 their	
conformational	 rigidity	 to	 avoid	 intramolecular	 cyclometalation	 reactions	 that	 can	 occur	 via	 C−H	 bond	
activation	of	the	downward	pointing	alkyl	and	aryl	NHC	appendages.2,3	 In	particular,	we	have	focused	our	
efforts	on	IBioxMe4,	which	shares	many	structural	similarities	with	the	commonly	employed	ItBu	ligand	that	
has	been	shown	to	undergo	cyclometalation	reactions	when	partnered	with	reactive	late	transition	metal	
fragments	(Scheme	1).4,5		
	
Chart	1:	IBiox	ligands	developed	by	Glorius.	
	
	
	
Scheme	1:	Hypothesized	reactivity	attenuation.	
	
	
	
Our	 investigations	 to	 date	 have	 supported	 the	 hypothesized	 reactivity	 attenuation,	 contrasting	 facile	
cyclometalation	reactions	observed	in	reactions	of	ItBu	with	dimeric	rhodium	and	iridium	precursors.5	In	the	
case	of	rhodium,	formally	14	VE	Rh(I)	complexes	have	been	isolated	and	fully	characterised	in	solution	and	
the	 solid-state:	 [Rh(IBioxMe4)2(COE)]+	A	 and	 [Rh(IBioxMe4)3]+	B	 (COE	=	 cyclooctene,	Scheme	2).6	 The	 rigid	
geometry	 of	 IBioxMe4	 appears	 to	 prohibit	 the	 adoption	 of	 any	 significant	 agostic	 interactions	 and	
remarkably,	despite	the	high	degree	of	electronic	unsaturation,	the	homoleptic	complex	displays	complete	
solution	 stability	 (CD2Cl2	 or	 1,2-difluorobenzene,	 48	 h	 at	 293	 K).	 Attempts	 to	 prepare	 analogous	 iridium	
complexes	lead	instead	to	intermolecular	C–H	bond	activation	of	the	fluoroarene	solvents	employed	(i.e.	C,	
D	in	Scheme	2).7	Such	reactivity	is	fully	inline	with	the	more	energetically	accessible	higher	oxidation	states	
of	the	heavier	group	9	congener	and	reinforces	the	ability	to	partner	IBioxMe4	with	reactive	metal	centres	
without	 intramolecular	 activation.8	 Cyclometalation,	 double	 cyclometalation	 and	dehydrogenation	 of	 the	
N-alkyl	and	aryl	substituents	of	NHC	ligands	are	otherwise	well	documented	for	iridium	systems.5b,5c,9	
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Scheme	2:	Low	coordinate	rhodium	and	iridium	IBioxMe4	complexes	(L	=	IBioxMe4).a	
	 	
a	M	=	Rh,	Arf	=	2,3-C6H3F2;	Ir,	Arf	=	2-C6H4F,	2,3-C6H3F2	,	2,4,6-C6H2F3.		
	
The	4-coordinate	 Ir(III)	 complex	C	was	 implicated	 in	 the	preparation	of	D	 (Arf	=	2,3-C6H3F2)	 from	the	well	
defined	Ir(I)	precursor	1.	While	we	were	not	able	to	directly	isolate	C,	its	formulation	was	substantiated	in	
situ	using	1H	and	19F	NMR	spectroscopy	and	through	reaction	with	2,2’-bipyridine,	which	afforded	a	more	
readily	handled,	coordinately	saturated	product.	With	these	results	in	mind	and	intrigued	by	the	possibility	
of	 accessing	 reactive	 iridium	 bis(NHC)	 synthons,	we	 now	 report	 our	 efforts	 at	 preparing	 iridium	 hydride	
species	 of	 the	 type	 {Ir(IBioxMe4)2(H)2}+	 and	 their	 subsequent	 reactivity,	 principally	 with	 alkenes.	
Compounded	by	potentially	facile	reductive	elimination	of	dihydrogen	as	a	thermodynamic	driving	force,10	
low-coordinate	iridium	hydride	species	such	as	these	represent	good	targets	to	test	the	robustness	of	IBiox	
ligands.		
	
	
	
Results	and	discussion	
With	 the	 dihydride	 bis(NHC)	 complex	 [Ir(ItBu)2(H)2]+	 E	 as	 a	 structural	 precedent,5b	 the	 preparation	 and	
isolation	of	the	direct	IBioxMe4	analogue	2	was	targeted	(Scheme	3).	Complex	E	is	formally	14	VE	Ir(III)	and	
stabilised	in	the	solid-state	by	the	formation	of	strong	agostic	interactions	from	the	tert-butyl	substituents	
of	the	NHC:	interactions	characterised	by	short	Ir···HC	contacts	of	2.653(10)	Å.	Given	the	apparent	stability	
of	IBioxMe4	to	intramolecular	activation,	the	synthetic	route	associated	with	E	 involving	hydrogenation	of	
bis-cyclometalated	 [Ir(ItBu’)2]+	 is	 not	 practical.	 Instead,	 the	 preparation	 of	 2	 was	 attempted	 through	
reaction	of	isolated	1	with	dihydrogen	(1	atm)	following	halide	extraction	using	excess	(2.0	eqv)	Na[BArF4]	
(ArF	=	3,5-C6H3(CF3)2)	in	1,2-difluorobenzene	solution	(293	K).	Analysis	of	the	reaction	mixture	using	1H	NMR	
spectroscopy	 after	 5	 min	 and	 placing	 under	 an	 argon	 atmosphere	 showed	 complete	 conversion	 of	 the	
starting	material	into	a	new	hydride	species,	characterised	by	broad	singlet	resonances	at	δ	4.27,	1.62,	and	
-35.85	 in	a	4:12:1	 ratio,	 alongside	 cyclooctane	 (COA,	 Scheme	3).	Repeating	 the	 reaction	 instead	with	0.5	
eqv	 Na[BArF4]	 resulted	 in	 the	 formation	 of	 a	 compound	 with	 the	 same	 spectroscopic	 characteristics,	
suggesting	 that	 the	 chloro-bridged	 Ir(III)	 dimer	 [{Ir(IBioxMe4)2(H)2}2Cl][BArF4]	 3	 is	 formed	 in	 both	 cases,	
rather	than	monomeric	2.	 Indeed	this	dimeric	complex	was	subsequently	 isolated	 in	77%	yield	under	the	
latter	 conditions	 and	 fully	 characterised	 (vide	 infra,	 Figure	 1).	 The	 formation	 of	 3	 implicates	 the	
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intermediate	 presence	 of	 2	 in	 solution	 and	 either	 competitive	 binding	 to	 {Ir(IBioxMe4)2(H)2Cl}	 or	 partial	
solubility	 of	 NaCl	 in	 fluoroarene	 solution.	 With	 the	 IBioxMe4	 ligand	 less	 predisposed	 to	 formation	 of	
stabilizing	agostic	interactions	than	ItBu,	both	suggestions	are	in	accord	with	higher	expected	reactivity	of	2	
relative	to	Nolan’s	dihydride	complex	E.	
	
Scheme	3:	In	situ	preparation	and	derivatives	of	dihydride	complex	2	(L	=	IBioxMe4).a	
	
a	[BArF4]–	anions	omitted	for	clarity.	All	reactions	in	1,2-C6H4F2	at	293	K.	
	
Invariant	 1H	NMR	 spectra	 of	3	were	 recorded	 after	 24	 hours	 at	 ambient	 temperature	 in	 CD2Cl2	 and	 1,2-
C6H4F2,	 implying	 good	 solution	 stability;	 the	 19F{1H}	 NMR	 spectrum	 in	 CD2Cl2	 displayed	 only	 a	 signal	
attributed	to	the	[BArF4]–	anion.	Consistent	with	retention	of	the	dimeric	formulation	in	solution,	the	broad	
ligand	resonances	observed	at	δ	4.42	(16H)	and	1.64	(48H)	in	the	1H	NMR	spectrum	at	298	K	decoalesced	
on	cooling	to	250	K	(CD2Cl2,	500	MHz),	resolving	diastereotopic	methylene	(δ	4.31,	4.47;	2JHH	=	8.4	Hz)	and	
two	 different	 methyl	 signals	 (δ	 1.48,	 1.69).	 The	 4H	 hydride	 resonance	 also	 sharpened	 significantly	 on	
cooling	 from	 298	 to	 250	 K	 (fwhm	 =	 43	 Hz	 vs	 6	 Hz).	 At	 both	 temperatures	 the	 measured	 T1	 times	 are	
consistent	with	hydride	ligands	(375	ms	at	298	K;	276	ms	at	250	K).11	Further	cooling	to	200	K	resulted	in	
the	onset	of	broadening	implying	loss	of	both	possible	symmetry	planes	of	the	ligand	should	occur	 in	the	
slow	exchange	regime;	the	hydride	ligand	remained	sharp	(fwhm	=	6	Hz;	T1	=	446	ms).	To	account	for	these	
time-averaged	 spectra,	 a	 dissociative	 mechanism	 is	 suggested,	 involving	 fragmentation	 of	 3	 into	
{Ir(IBioxMe4)2(H)2Cl}	and	2	followed	by	rotation	of	the	IBioxMe4	ligand	about	the	Ir-CNCN	bond.	Inspection	of	
the	solid-state	structure	of	3	indicates	that	an	alternative	suggestion	involving	such	a	rotation	in	the	intact	
dimer	is	unlikely	due	to	the	close	proximity	of	the	NHC	ligands	to	each	other	(Figure	1).		
	
The	bridged	 structure	of	3	 in	 the	 solid-state	 is	 rather	unusual,	with	an	offset	 (|C3/18-Ir1-IrA-C3A/18A|	=	
50.3(2)/47.7(2)º)	 face-to-face	 alignment	 of	 the	 coordinated	 NHC	 ligands,	 almost	 linear	 bridging	 chloride	
ligand	(Ir1-Cl2-Ir1A	=	171.47(7)º)	and	unequal	Ir–Cl	bonds	(2.4499(13)	vs	2.4817(13)	Å).	The	closest	iridium	
NHC	precedent	featuring	a	single	bridging	chloride	ligand	[{Ir(COD)(IMes)}2Cl]+	(COD	=	1,5-cyclooctadiene)	is	
in	contrast	characterised	by	a	bent	bridging	chloride	ligand	(Ir–Cl–Ir	=	126.91(8)º)	and	more	symmetrical	Ir–
Cl	distances	(2.407(2)/2.418(2)	Å),12	however,	near	linear	arrangements	have	been	observed	in	iridium(III)	
complexes	bearing	chelating	or	mono-dentate	phosphine	ligands.13	
	
Despite	 the	 dimeric	 resting	 state,	 mixtures	 of	 3	 and	 Na[BArF4]	 act	 as	 a	 latent	 source	 of	 the	 reactive	
monomeric	fragment	2	in	1,2-difluorobenzene.	As	evidence,	reaction	of	isolated	3	and	2,2’-bipyridine	in	the	
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presence	of	1.1	eqv	Na[BArF4]	resulted	 in	quantitative	formation	of	the	6-coordinate	dihydride	complex	4	
(Scheme	3).	Rather	than	using	the	isolated	dimeric	product,	mixtures	of	3	and	Na[BArF4]	generated	 in	situ	
from	hydrogenation	of	1	in	the	presence	of	a	slight	excess	of	Na[BArF4]	(typically	1.1	eqv)	provides	a	more	
synthetically	 convenient	means	 for	generation	of	2	 in	 solution.	 In	 this	way,	dihydride	complexes	4	 and	5	
were	 straightforwardly	 isolated	 in	 64%	 and	 74%	 yield,	 respectively,	 through	 reaction	 of	 2	 with	 2,2’-
bipyridine	 and	 IBioxMe4,	 respectively	 (Scheme	 3).	 Both	 these	 new	 complexes	 were	 characterised	 in	 the	
solid-state	by	X-ray	diffraction,	including	the	location	of	the	hydride	ligands	in	4	from	the	Fourier	difference	
map	 (Figure	 1).	 The	metrics	 about	 the	metal	 centre	 are	 notable	 for	 being	 in	 very	 good	 agreement	with	
those	 of	 their	 respective	 aryl	 fluoride	 analogues	 trans-[Ir(IBioxMe4)2(2,2’-bipyridine)(C6H3F2)(H)]+	 and	D.7	
Verification	 of	 the	 structures	 in	 solution	 was	 readily	 achieved	 through	 the	 presence	 of	 low	 frequency	
hydride	resonances	at	δ	-21.33	(T1	=	701	ms)	and	-28.57	(T1	=	940	ms),	respectively,	 in	CD2Cl2	(298	K,	500	
MHz).		
	
	
Figure	 1:	 Solid-state	 structures	 of	 iridium	 IBioxMe4	 hydride	 complexes.	 Thermal	 ellipsoids	 for	 selected	
atoms	 are	 drawn	at	 the	 50%	probability	 level;	most	 hydrogen	 atoms	 (hydrides	 located	 in	4),	 anions	 and	
solvent	(5)	are	omitted	for	clarity;	only	one	of	the	two	independent	molecules	shown	for	5.	Selected	bond	
lengths	 (Å)	and	angles	 (º):	3	–	 Ir1-Cl2,	2.4499(13);	 Ir1A-Cl2,	2.4817(13);	 Ir1-C3,	2.047(4);	 Ir1-Cl8,	2.038(4);	
Ir1A-C3A,	 2.038(4);	 Ir1A-C18A,	 2.034(5);	 Ir1-Cl2-Ir1A,	 171.47(7);	 C3-Ir1-C18,	 176.35(18);	 C3A-Ir1A-C18A,	
178.62(19);	All	ΘNHC	>	175;	4	–	Ir1-H2	=	Ir1-H3,	1.36(2);	Ir1-C4,	2.064(3);	Ir1-C19,	2.053(3);	Ir1-N34,	2.175(2);	
Ir1-N45,	2.199(2);	C4-Ir1-C19,	161.10(10);	ΘNHC(@C4),	170.1(3);	ΘNHC(@C19),	174.4(3);	5	–	Ir1-C2,	2.043(2);	
Ir1-C17,	2.050(3);	Ir1-C32,	2.124(3);	C2-Ir1-C17,	166.70(10);	C2-Ir1-C32,	97.55(9);	C17-Ir1-C32,	95.55(10);	all	
ΘNHC(@C2,C17,C32)	 >	 175;	 Ir1A-C2A,	 2.059(2);	 Ir1A-C17A,	 2.051(3);	 Ir1A-C32A,	 2.115(3);	 C2A-Ir1A-C17A,	
163.39(10);	 C2A-Ir1A-C32A,	 98.31(9);	 C17A-Ir1A-C32A,	 98.16(10);	 ΘNHC(@C2A),	 173.8(2);	 ΘNHC(@C17A),	
173.3(3);	ΘNHC(@C32A),	179.3(3).14	
	
To	further	explore	the	reactivity	of	the	{Ir(IBioxMe4)2(H)2}+	fragment	2	 in	situ,	mixtures	of	3	and	Na[BArF4]	
were	 reacted	 with	 ethylene	 (1	 atm)	 and	 COE	 (10	 eqv)	 –	 Scheme	 4.	 The	 former	 reaction	 with	 ethylene	
resulted	in	rapid	and	quantitative	formation	of	the	bis-ethylene	complex	trans-[Ir(IBioxMe4)2(C2H4)2][BArF4]	
6	 alongside	 a	 stoichiometric	 amount	 of	 ethane	 (observed)	 within	 15	 min,	 as	 indicated	 by	 1H	 NMR	
spectroscopy.	 Under	 similar	 conditions,	 addition	 of	 ethylene	 to	 the	 related	 but	 less	 sterically	 congested	
{Ir(PPh3)2(H)2}+	 fragment	 has	 been	 shown	 to	 instead	 result	 in	 formation	 of	 a	 tris-ethylene	 adduct;	 trans-
[Ir(PPh3)2(C2H4)3]+.15	The	new	complex	was	also	prepared	directly	from	1	in	77%	isolated	yield.	No	significant	
reactions	were	detected	by	1H	NMR	spectroscopy	after	24	h	when	isolated	6	was	dissolved	in	either	CD2Cl2	
or	 1,2-C6H4F2	 solution,	 consistent	with	 good	 solution	 stability	 at	 ambient	 temperature	 (293	 K).	 In	 CD2Cl2	
solution,	D2h	symmetry	is	evident	by	1H	NMR	spectroscopy	across	a	wide	temperature	range	(200	–	298	K,	
500	MHz;	and	also	by	13C	NMR	spectroscopy	at	298	K,	126	MHz).	In	contrast,	the	X-ray	structure	(Figure	2)	
reveals	 an	 interesting	 and	 low	 symmetry	 arrangement	 of	 the	 ethylene	 ligands	 in	 the	 solid-state;	 one	
ethylene	ligand	binds	75.3(2)º	to	the	coordination	plane	(C2,	C3)	while	the	other	adopts	a	more	co-planar	
arrangement	 (C4,	 C5;	 29.3(2)º).16	 Associated	with	 the	 approximate	orthogonal	 geometry	 (|CC=C-Cnt(C=C)-
Cnt(C=C’)-CC=C’|min	=	75.8(4)º;	Cnt	=	centroid),	 the	perpendicular	ethylene	 ligand	has	a	 shorter	 Ir-Cnt(C=C)	
distance	 (2.048(3)	 vs.	 2.105(3)	 Å)	 and	 elongated	 C=C	 bond	 length	 (1.387(5)	 vs.	 1.367(5)	 Å),17	 suggesting	
stronger	 binding	 than	 the	 co-planar	 ligand.	 Although	 unstable	 with	 respect	 to	 ethylene	 dissociation	 in	
solution,	 a	 similar	 twisted	 bis-ethylene	 configuration	 has	 been	 observed	 in	 the	 disordered	 solid-state	
structure	 of	 a	 five	 coordinate	 Ir(I)-PCP	 pincer	 complex	 (|CC=C-Cnt(C=C)-Cnt(C=C’)-CC=C’|min	 =	 39(2)	 [43%]	 /	
70(3)	[57%]º	).18	Other	bis-ethylene	iridium(I)	complexes	characterised	by	X-ray	diffraction	bear	either	cis-
square	planar	 (d6)	or	cis-trigonal	bipyramidal	 (d8)	geometries	with	parallel	ethylene	 ligands.19	A	search	of	
the	Cambridge	Structural	Database	(v.	5.36)	further	emphasises	the	peculiarity	of	this	geometry,	with	only	
8%	 of	 deposited	 transition-metal	 complexes	 containing	 two	 or	 more	 ethylene	 ligands,	 featuring	 similar	
ethylene	geometries	(i.e.	within	20º	of	ideal	orthogonal	geometry).20		
	
Scheme	4:	Reactions	of	dihydride	complex	2	with	ethylene	and	COE	(L	=	IBioxMe4).a	
	
a	[BArF4]–	anions	omitted	for	clarity.	All	reactions	in	1,2-C6H4F2	at	293	K;	reactions	with	CO	and	C2H4	were	
carried	out	at	1	atm	pressure,	reactions	with	COE	used	excess	alkene	(10	eqv	/	Ir).	
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Figure	2:	Solid-state	structures	of	6	(left),	7	(centre)	and	8	(right).	Thermal	ellipsoids	for	selected	atoms	are	
drawn	at	the	50%	probability	level;	most	hydrogen	atoms	and	anions	are	omitted	for	clarity.	Selected	bond	
lengths	(Å)	and	angles	(º):	6	–	Ir1-Cnt(C2,C3),	2.048(3);	Ir1-Cnt(C4,C5),	2.105(3);	Ir1-C6,	2.071(3);	Ir1-C21,	
2.065(3);	C2-C3,	1.387(5);	C4-C5,	1.367(5);	C6-Ir1-C21,	174.48(10);	Cnt(C2,C3)-Ir1-Cnt(C4,C5),	173.17(13);	
ΘNHC(@C6),	173.8(3);	ΘNHC(@C21),	178.2(3);	7–	Ir1-Cnt(C2,C3),	2.066(2);	Ir1-Cnt(C6,C7),	2.047(2);	Ir1-C10,	
2.088(2);	Ir1-C25,	2.084(2);	C2-C3,	1.398(3);	C6-C7,	1.395(3);	Cnt(C2,C3)-Ir1-Cnt(C6,C7),	85.28(9);	C10-Ir1-
C25,	100.07(8);	ΘNHC(@C10),	167.6(3);	ΘNHC(@C25),	176.9(3);	8	–	Ir1-C2,	1.913(3);	Ir1-C4,	1.899(3);	Ir1-C6,	
2.064(3);	Ir1-C21,	2.064(2);	C2-Ir1-C4,	170.13(14);	C6-Ir1-C21,	177.15(11);	All	ΘNHC	>	175.14		
	
In	order	to	further	understand	the	structure	of	6,	a	series	of	model	conformational	isomers	bearing	instead	
the	 less	 bulky	 IBioxH4	 ligand	 were	 optimised	 employing	 Density	 Functional	 Theory	 (DFT;	 BP86-D3/def2-
TZVPP).	These	optimisations	attempted	to	place	the	ethylene	ligands	in	ideal	orthogonal	(6’),	perpendicular	
(6a’)	 or	 co-planar	 (6b’)	 orientations	 –	 Figure	 3.	 In	 contrast	 to	 the	 distorted	 geometry	 observed	
experimentally	for	6,	the	ethylene	ligands	in	the	optimised	structure	of	6’	bind	with	ideal	angles	(0º,	90º)	
with	 respect	 to	 the	coordination	plane.	The	distorted	geometry	was	also	 retained	on	optimisation	of	 the	
full	system	(i.e.	6),	suggesting	the	methyl	substituents	counteract	adoption	of	an	ideal	orthogonal	ethylene	
orientation	 (see	 Figure	 S14).	 Nevertheless,	 6’	 was	 found	 to	 be	 the	 lowest	 energy	 model	 conformer.	
Beginning	the	optimisation	with	the	alkene	ligands	perpendicular	to	the	NHC-M-NHC	vector	led	to	adoption	
of	 a	 complex	with	 pseudo	 saw-horse	 geometry	 6a’,	 12.1	 kJ	 mol-1	 higher	 in	 energy	 than	 6’,	 where	 the	
ethylene	 ligands	 are	 bowed	 away	 from	 linearity	 (Cnt(C=C)-Ir-Cnt(C=C’)	 =	 145º).	 Restraining	 the	 ethylene	
ligands	in	an	alternative	parallel	alignment	also	led	to	departure	from	square	planar	geometry	and	is	much	
more	destabilising,	with	6b’	calculated	to	be	80.4	kJ	mol-1	higher	in	energy	than	6’.21	The	relative	energies	
of	these	isomers	lead	us	to	hypothesise	that	the	high	symmetry	of	6	observed	in	solution	(200	–	298	K)	is	a	
result	 of	 time-averaged	 fluxionality	 originating	 from	 facile	 and	 synchronized	 rotation	 of	 the	 ethylene	
ligands	about	the	respective	metal-ligand	vectors	–	the	high	energy	calculated	for	6b’	 is	 incommensurate	
with	 independent	rotation.	Energy	Decomposition	Analysis	 (EDA-NOCV)	of	 the	 isomers	 indicated	that	 the	
perpendicular	 ethylene	 ligand	 in	 6’	 shows	 a	 higher	 intrinsic	 bond	 strength	 than	 the	 co-planar	 ligand	
(ΔEint(C2H4)	=	-261.5	(perpendicular),	-238.0	kJ	mol-1	(co-planar);	Table	S1	and	Figure	S15).	This	is	consistent	
with	 the	 experimental	 metrics	 and	 inspection	 of	 the	 deformation	 densities	 from	 NOCV	 analysis	 for	 the	
binding	of	the	ethylene	ligands	in	6’	shows	significantly	larger	absolute	M→L	and	particularly	L→M	bonding	
interactions	for	the	perpendicular	ligand,	summing	up	to	an	increased	orbital	 interaction	energy	(ΔEorb	=	-
518.2	kJ	mol-1	(perpendicular),	-446.1	kJ	mol-1	(co-planar)).	This	energy	gain	is	offset	by	a	higher	preparation	
energy	 for	 the	 perpendicular	 ligand	 in	 6’	 (|ΔΔEprep(perpendicular	 –	 co-planar)|	 =	 23.8	 kJ	 mol-1)	 and	
ultimately	 leads	 to	 essentially	 equal	 dissociation	 energies	 for	 the	 ethylene	 ligands	 (De(C2H4)	 =	 167.4	
(perpendicular),	 167.6	 kJ	mol-1	 (co-planar)).	 The	 ethylene	 dissociation	 energy	 is	 similar	 in	6a’	 (De(C2H4)	 =	
160.2	kJ	mol-1),	however,	those	in	6b’	are	much	less	strongly	bound	(De(C2H4)	=	87.7	kJ	mol-1)	due	to	lower	
intrinsic	bond	strength	(ΔEint	=	-222.3	kJ	mol-1)	and	higher	preparation	energy	associated	with	the	distorted	
metal	fragment	(Table	S1).	
	
	
6’	 6a’	 6b’	
Erel	=	0.0	kJ	mol-1	 Erel	=	+12.1	kJ	mol-1	 Erel	=	+80.4	kJ	mol-1	
	
Figure	3:	Optimised	geometries	of	model	isomers	of	6,	annotated	with	selected	bond	lengths	(Å)	and	angles	
(º)	–	metrics	associated	with	the	alkene	centroids	in	purple.21		
	
When	mixtures	of	3	and	Na[BArF4]	were	reacted	with	an	excess	of	COE	(10	eqv)	in	1,2-difluorobenzene	at	
293	K,	an	interesting	transfer	dehydrogenation	reaction	was	observed	by	1H	NMR	spectroscopy	leading	to	
quantitative	 formation	 of	 a	 complex	 bearing	 η4-coordinated	 COD	 after	 48	 hours,	 cis-
[Ir(IBioxMe4)2(COD)][BArF4]	7,	alongside	sacrificial	hydrogenation	of	two	equivalents	of	COE	to	COA	(Scheme	
4,	Figure	2).	When	the	reaction	was	performed	on	a	preparative	scale,	7	was	obtained	in	68%	isolated	yield.	
The	stoichiometry	of	the	reaction	implicates	initial	generation	of	a	reactive	12	VE	fragment	{Ir(IBioxMe4)2}+	
through	 hydrogenation	 of	 COE.	 Consistent	 with	 this	 suggestion,	 7	 could	 also	 be	 prepared	 by	 transfer	
dehydrogenation	on	a	similar	timescale,	employing	instead	1,	Na[BArF4]	and	excess	COE	–	and	in	this	case	
only	one	equivalent	of	COA	was	generated.	A	hydride	species	characterised	by	a	1H	resonance	at	δ	-29.26	is	
the	 major	 intermediate	 observed	 in	 both	 cases,	 which	 we	 tentatively	 assign	 to	 trans-
[Ir(IBioxMe4)2(COE)(H)2]+	 (see	 Figure	 S13).	 Iridium	 complexes	 and	 in	 particular	 iridium	pincer	 compounds	
are	 well	 documented	 to	 promote	 dehydrogenation	 reactions.22,23	 Most	 closely	 related	 to	 the	 systems	
studied	here	 is	work	reported	by	Crabtree,	who	described	analogous	formation	of	cis-[Ir(PPh3)2(COD)]+	by	
transfer	dehydrogenation	of	COE.24	The	possibility	of	adapting	this	dehydrogenation	reaction	to	a	catalytic	
processes	would	be	interesting,	however,	is	prohibited	in	this	case	by	the	strongly	coordinated	COD	ligand	
(i.e.	 product	 inhibition).	 A	 feature	 of	 7	 quantified	 by	 very	 slow	 displacement	 of	 the	 diene	 under	 an	
atmosphere	of	CO	at	293	K	(t1/2	=	77	h)	to	afford	trans-[Ir(IBioxMe4)2(CO)2][BArF4]	8	–	the	structure	of	which	
was	 verified	 by	 independent	 synthesis	 from	 1	 (Scheme	 4,	 Figure	 2).	 For	 comparison,	 and	 as	 expected,	
alkene	substitution	was	an	order	of	magnitude	more	rapid	in	6	(t1/2	=	4	h).	
	
	
	
Summary		
Following	on	from	previous	work	employing	the	tetra	methyl	IBiox	derivative	(IBioxMe4),	we	have	reported	
a	method	for	accessing	the	formally	14	VE	iridium(III)	hydride	fragment	{Ir(IBioxMe4)2(H)2}+	2	in	situ	through	
simultaneous	 hydrogenation	 and	 halogen	 ion	 abstraction	 from	 trans-[Ir(IBioxMe4)2(COE)Cl]	 1	 in	 1,2-
difluorobenzene.	 The	 halide	 abstraction	 does	 not	 spontaneously	 proceed	 to	 completion	 and	 instead	
dimeric	 [{Ir(IBioxMe4)2(H)2}2Cl][BArF4]	 3	 acts	 as	 the	 reservoir	 for	 2	 (in	 the	 presence	 of	 excess	 Na[BArF4]).	
Complex	3	was	isolated	and	fully	characterised	in	solution	and	the	solid-state;	both	sets	of	data	support	the	
dimeric	 formulation,	 although	 a	 study	 of	 the	 isolated	 complex	 using	 variable	 temperature	 1H	 NMR	
spectroscopy	suggested	dynamic	fragmentation	of	3	occurs	on	the	NMR	time	scale	in	solution.	Consistent	
with	 this	 characteristic,	 stable	 dihydride	 complexes	 trans-[Ir(IBioxMe4)2(2,2’-bipyridine)(H)2][BArF4]	 4	 and	
[Ir(IBioxMe4)3(H)2][BArF4]	 5	 were	 readily	 obtained	 through	 in	 situ	 trapping	 of	 2	 using	 2,2’-bipyridine	 and	
IBioxMe4.	 Building	 on	 these	 results,	mixtures	 of	 3	 and	 Na[BArF4]	 were	 used	 as	 a	 latent	 source	 of	 2	 and	
reacted	 with	 excess	 ethylene	 and	 COE	 to	 afford	 trans-[Ir(IBioxMe4)2(C2H4)2][BArF4]	 6	 and	 cis-
[Ir(IBioxMe4)2(COD)][BArF4]	7,	 respectively,	 through	sacrificial	hydrogenation	of	 the	alkenes;	both	are	also	
accessible	from	halogen	ion	abstraction	from	1	in	the	presence	of	the	alkene.	Complex	6	is	notable	for	the	
unusual	orthogonal	arrangement	the	trans-ethylene	ligands	adopt	in	the	solid-state,	a	conformation	unique	
for	d6	iridium	complexes	and	very	unusual	for	transition	metal	complexes	generally.	In	solution	6	is	stable,	
but	 highly	 fluxional	 on	 the	 NMR	 time	 scale	 (200	 –	 298	 K,	 500	 MHz);	 a	 feature	 we	 attribute	 to	 facile	
synchronized	 rotation	 of	 the	 ethylene	 ligands	 on	 the	 basis	 of	 DFT	 calculations.	 The	 formation	 of	 7	 via	
transfer	dehydrogenation	of	COE	has	literature	precedent,	but	importantly	further	reinforces	the	ability	to	
partner	 IBioxMe4	 with	 reactive	 metal	 centres	 capable	 of	 C–H	 bond	 activation,	 without	 intramolecular	
activation.	 Reaction	 of	 7	 with	 CO	 slowly	 formed	 trans-[Ir(IBioxMe4)2(CO)2][BArF4]	 8,	 but	 the	 equivalent	
reaction	with	bis-ethylene	complex	6	was	an	order	of	magnitude	faster,	quantifying	the	strong	coordination	
of	COD	in	7.	
	
	 	
Experimental	
General	experimental	methods	
All	manipulations	were	performed	under	an	atmosphere	of	argon,	using	Schlenk	and	glove	box	techniques.	
Glassware	was	oven	dried	at	150ºC	overnight	and	flamed	under	vacuum	prior	to	use.	Anhydrous	CH2Cl2	and	
heptane	 (<0.005%	 H2O)	 were	 purchased	 from	 ACROS	 or	 Aldrich	 and	 freeze-pump-thaw	 degassed	 three	
times	before	being	placed	under	argon.	CD2Cl2	and	1,2-C6H4F2	were	dried	over	CaH2,	vacuum	distilled	and	
the	latter	stored	over	thoroughly	vacuum-dried	3	Å	molecular	sieves.	C6H6,	C6D6	and	cis-cyclooctene	(COE)	
were	dried	over	Na	and	vacuum	distilled.	IBioxMe4,6	trans-[Ir(IBioxMe4)2(COE)Cl]	(1)7	and	Na[BArF4]25	were	
synthesised	using	 literature	protocols.	All	other	solvents	and	reagents	are	commercial	products	and	were	
used	as	received.	NMR	spectra	were	recorded	on	Bruker	DPX-400,	AV-400,	AV-500,	AVIIIHD-500	and	AVII-
700	 spectrometers	 at	 298	 K	 unless	 otherwise	 stated.	 1H	 NMR	 spectra	 recorded	 in	 1,2-C6H4F2	 were	
referenced	 using	 the	 highest	 intensity	 peak	 of	 the	 highest	 (δ	6.87)	 frequency	 fluoroarene	multiplets.	 19F	
NMR	spectra	recorded	in	1,2-C6H4F2	were	referenced	using	the	solvent	peak	at	δ	-138.75.	13C	NMR	spectra	
recorded	 in	 1,2-C6H4F2	 were	 referenced	 using	 an	 internal	 sealed	 capillary	 of	 C6D6.	 Chemical	 shirts	 are	
quoted	in	ppm	and	coupling	constants	in	Hz.	Microanalyses	were	performed	by	Stephen	Boyer	at	London	
Metropolitan	University.	
	
Synthesis	of	new	compounds	
[{Ir(IBioxMe4)2(H)2}2Cl][BArF4]	(3)	
To	a	mixture	of	trans-[Ir(IBioxMe4)2(COE)Cl]	(0.050	g,	0.066	mmol)	and	Na[BArF4]	(0.029	g,	0.033	mmol)	was	
added	 1,2-C6H4F2	 (2	 mL)	 under	 a	 H2	 atmosphere	 (1	 atm).	 The	 yellow	 solution	 was	 stirred	 at	 room	
temperature	 for	 30	min	 before	 the	 solvent	was	 removed	 under	 vacuum.	 The	 resulting	 yellow	 solid	was	
dissolved	in	dichloromethane	(2	mL),	filtered	and	layered	with	heptane	(15	mL)	to	afford	3	on	diffusion	at	
277	K.	Yield	=	0.054	g	(77%,	orange	crystals).		
	
1H	NMR	(1,2-C6H4F2/C6D6,	400	MHz):	δ	8.12	–	8.16	(m,	8H,	ArF),	7.50	(br,	4H,	ArF),	4.27	(s,	16H,	OCH2),	1.62	
(s,	48H,	CH3),	 -35.85	(s,	4H,	 IrH).	1H	NMR	 (CD2Cl2,	500	MHz):	δ	7.69	–	7.75	(m,	8H,	ArF),	7.56	(br,	4H,	ArF),	
4.42	(s,	16H,	OCH2),	1.64	(s,	48H,	CH3),	-36.06	(br,	4H,	IrH,	T1	=	375	ms).	1H	NMR	(CD2Cl2,	500	MHz,	250	K):	δ	
7.69	–	7.75	(m,	8H,	ArF),	7.55	(br,	4H,	ArF),	4.48	(br	d,	2JHH	=	8.3,	8H,	OCH2),	4.31	(br	d,	2JHH	=	8.3,	8H,	OCH2),	
1.69	(s,	24H,	CH3),	1.49	(s,	24H,	CH3),	-36.02	(s,	4H,	IrH,	T1	=	267	ms).	1H	NMR	(CD2Cl2,	500	MHz,	200	K):	δ	
7.69	–	7.75	(m,	8H,	ArF),	7.54	(br,	4H,	ArF),	4.46	(d,	2JHH	=	8.3,	8H,	OCH2),	4.28	(br	d,	2JHH	=	8.3,	8H,	OCH2),	
1.65	 (s,	 24H,	CH3),	 1.42	 (s,	 24H,	CH3),	 -36.05	 (s,	 4H,	 IrH,	T1	 =	446	ms).	 13C{1H}	NMR	 (CD2Cl2,	 101	MHz):	δ	
162.3	(q,	1JBC	=	50,	ArF),	157.1	(br,	NCN),	135.4	(s,	ArF),	129.4	(qq,	2JFC	=	32,	3JBC	=	3,	ArF),	125.2	(q,	1JFC	=	272,	
ArF),	 125.0	 (s,	 COCH2),	 118.0	 (s,	 sept,	3JFC	=	 4,	ArF),	 88.3	 (s,	OCH2),	 61.1	 (s,	 C(CH3)2),	 26.3	 (vbr,	 CH3).	Anal.	
Calcd	for	C76H80BClF24Ir2N8O8	(2120.18	gmol-1):	C,	43.05;	H,	3.80;	N,	5.29.	Found:	C,	43.12;	H,	3.72;	N,	5.31.	
	
trans-[Ir(IBioxMe4)2(2,2’-bipyridine)(H)2][BArF4]	(4)	
To	a	mixture	of	trans-[Ir(IBioxMe4)2(COE)Cl]	(0.025	g,	0.033	mmol)	and	Na[BArF4]	(0.032	g,	0.037	mmol)	was	
added	1,2-C6H4F2	(1	mL)	under	a	H2	atmosphere	(1	atm).	The	solution	was	degassed	and	transferred	onto	
solid	 2,2’-bipyridine	 (0.006	 g,	 0.037	 mmol)	 under	 argon.	 The	 deep	 red	 solution	 was	 stirred	 at	 room	
temperature	 for	 one	 hour	 and	 then	 diluted	with	 heptane	 (0.5	mL)	 before	 filtration.	 Layering	 the	 filtrate	
with	heptane	afforded	the	red	crystalline	product	on	diffusion.	Yield	=	0.034	g	(64%,	red	crystals).	
	
	1H	NMR	(1,2-C6H4F2/C6D6,	400	MHz):	δ	9.28	(d,	3JHH	=	5.5,	2H,	C6,6’H{bipy}),	8.11	–	8.17	(m,	8H,	ArF),	7.96	(d,	
3JHH	 =	 8.1,	 2H,	 C3,3’H{bipy}),	 7.66	 (t,	 3JHH	 =	 7.9,	 2H,	 C4,4’H{bipy}),	 7.49	 (br,	 4H,	 ArF),	 7.22	 (t,	 3JHH	 =	 6.6,	 2H,	
C5,5’H{bipy}),	4.03	(s,	8H,	OCH2),	1.23	(s,	24H,	CH3),	-21.26	(s,	2H,	IrH).	1H	NMR	(CD2Cl2,	500	MHz):	δ	9.24	(d,	
3JHH	 =	 5.4,	 2H,	 C6,6’H{bipy}),	 8.14	 (d,	 3JHH	 =	 8.1,	 2H,	 C3,3’H{bipy}),	 7.91	 (td,	 3JHH	 =	 7.9,	 4JHH	 =	 1.5,	 2H,	
C4,4’H{bipy}),	7.69	–	7.76	(m,	8H,	ArF),	7.56	(br,	4H,	ArF),	7.40	(ddd,	3JHH	=	7.2,	5.5,	4JHH	=	1.3,	2H,	C5,5’H{bipy}),	
4.25	 (s,	8H,	OCH2),	1.30	 (s,	24H,	CH3),	 -21.33	 (s,	2H,	 IrH,	T1	=	701	ms).	 13C{1H}	NMR	 (CD2Cl2,	101	MHz):	δ	
162.3	(q,	1JBC	=	50,	ArF),	158.1	(s,	NCN),	155.1	(s,	C6,6’{bipy}),	138.6	(s,	C2,2’{bipy}),	137.1	(s,	C4,4’{bipy}),	135.4	
(s,	 ArF),	 129.4	 (qq,	 2JFC	=	 32,	3JBC	=	 3,	 ArF),	 126.6	 (s,	 C5,5’{bipy}),	 125.4	 (s,	 COCH2),	 125.1	 (q,	1JFC	=	 271,	ArF),	
123.9	(s,	C3,3’{bipy}),	118.0	(sept,	3JFC	=	4,	ArF),	87.9	(s,	OCH2),	63.7	(s,	C(CH3)2),	25.3	(s,	CH3).	Anal.	Calcd	for	
C64H54BF24IrN6O4	(1630.16	gmol-1):	C,	47.16;	H,	3.34;	N,	5.16.	Found:	C,	47.23;	H,	3.21;	N,	5.15.	
	
[Ir(IBioxMe4)3(H)2][BArF4]	(5)	
To	a	mixture	of	trans-[Ir(IBioxMe4)2(COE)Cl]	(0.0075	g,	0.010	mmol),	Na[BArF4]	(0.0097	g,	0.011	mmol)	and	
IBioxMe4	(0.0023	g,	0.011	mmol)	was	added	1,2-C6H4F2	(1	mL)	under	a	H2	atmosphere	(1	atm).	The	solution	
was	 stirred	 at	 room	 temperature	 for	 16	h,	 then	 freeze-pump-thaw	degassed	 three	 times	within	 6	 h	 and	
placed	under	argon.	The	solvent	was	removed	under	vacuum	and	the	resulting	the	red	solid	extracted	with	
dichloromethane	(1	mL)	to	afford	5	after	layering	the	solution	with	heptane	(12	mL).	Yield	=	0.012	g	(74%,	
red	crystals).	
	
1H	NMR	 (1,2-C6H4F2/C6D6,	 400	MHz):	δ	 8.12	 –	 8.17	 (m,	 8H,	 ArF),	 7.49	 (br,	 4H,	 ArF),	 4.18	 –	 4.30	 (m,	 12H,	
OCH2),	1.63	(s,	6H,	CH3),	1.62	(s,	6H,	CH3),	1.59	(s,	6H,	CH3),	1.33	(s,	6H,	CH3),	1.06	(s,	6H,	CH3),	1.04	(s,	6H,	
CH3),	-28.47	(s,	2H,	IrH).	1H	NMR	(CD2Cl2,	500	MHz):	δ	7.69	–	7.74	(m,	8H,	ArF),	7.56	(br,	4H,	ArF),	4.49	(d,	2JHH	
=	8.4,	2H,	OCH2),	4.44	(d,	2JHH	=	8,	2H,	OCH2),	4.41	(d,	2JHH	=	8,	2H,	OCH2),	4.40	(d,	2JHH	=	8,	2H,	OCH2),	4.37	(d,	
2JHH	=	8.4,	2H,	OCH2),	4.36	(d,	2JHH	=	8.4,	2H,	OCH2),	1.69	(s,	6H,	CH3),	1.66	(s,	6H,	CH3),	1.62	(s,	6H,	CH3),	1.42	
(s,	6H,	CH3),	1.15	(s,	6H,	CH3),	1.11	(s,	6H,	CH3),	-28.57	(s,	2H,	 IrH,	T1	=	940	ms).	13C{1H}	NMR	 (CD2Cl2,	126	
MHz):	δ	166.3	({t,	2JCH	=	14},	NCN),	162.3	(q,	1JBC	=	50,	ArF),	151.5	({t,	2JCH	=	6},	NCN),	135.4	(s,	ArF),	129.4	(qq,	
2JFC	=	32,	3JBC	=	3,	ArF),	127.2	(s,	COCH2),	126.6	(s,	COCH2),	125.7	(s,	COCH2),	125.2	(q,	1JFC	=	272,	ArF),	118.0	
(s,	sept,	3JFC	=	4,	ArF),	88.4	(s,	OCH2),	88.2	(s,	OCH2),	87.5	(s,	OCH2),	64.9	(s,	C(CH3)2),	63.9	(s,	C(CH3)2),	62.0	(s,	
C(CH3)2),	27.9	(s,	CH3),	26.7	(s,	CH3),	25.4	(s,	CH3),	25.2	(s,	CH3),	23.9	(s,	CH3),	23.8	(s,	CH3).	Anal.	Calcd	for	
C65H62BF24IrN6O6	(1682.24	gmol-1):	C,	46.41;	H,	3.72;	N,	5.00.	Found:	C,	46.34;	H,	3.58;	N,	5.13.	
	
trans-[Ir(IBioxMe4)2(C2H4)2][BArF4]	(6)	
To	a	mixture	of	trans-[Ir(IBioxMe4)2(COE)Cl]	(0.025	g,	0.033	mmol)	and	Na[BArF4]	(0.032	g,	0.037	mmol)	was	
added	1,2-C6H4F2	(2	mL)	under	an	ethylene	atmosphere	(1	atm).	The	yellow-orange	solution	was	stirred	at	
room	temperature	for	one	hour,	subsequently	diluted	with	heptane	(0.5	mL)	and	then	filtered.	Layering	the	
filtrate	with	 heptane	 afforded	 the	 orange	 crystalline	 product	 on	 diffusion.	 Yield	 =	 0.039	 g	 (77%,	 orange	
crystals).	
	
1H	NMR	(1,2-C6H4F2/C6D6,	400	MHz):	δ	8.11	–	8.16	(m,	8H,	ArF),	7.49	(br,	4H,	ArF),	4.24	(s,	8H,	OCH2),	3.11	(s,	
8H,	C2H4),	1.53	(s,	24H,	CH3).	1H	NMR	(CD2Cl2,	500	MHz):	δ	7.69	–	7.75	(m,	8H,	ArF),	7.56	(br,	4H,	ArF),	4.50	(s,	
8H,	OCH2),	3.20	(s,	8H,	C2H4),	1.68	(s,	24H,	CH3).	13C{1H}	NMR	(CD2Cl2,	126	MHz):	δ	162.3	(q,	1JBC	=	50,	ArF),	
145.9	 (s,	NCN),	135.4	 (s,	ArF),	129.4	 (qq,	 2JFC	=	32,	3JBC	=	3,	ArF),	127.2	 (s,	COCH2),	125.2	 (q,	1JFC	=	272,	ArF),	
118.0	 (sept,	3JFC	=	 4,	 ArF),	 88.2	 (s,	 OCH2),	 63.8	 (s,	 C(CH3)2),	 59.0	 (s,	 C2H4),	 25.8	 (s,	 CH3).	 Anal.	 Calcd	 for	
C58H52BF24IrN4O4	(1528.07	gmol-1):	C,	45.59;	H,	3.43;	N,	3.67.	Found:	C,	45.48;	H,	3.39;	N,	3.74.	
	
cis-[Ir(IBioxMe4)2(COD)][BArF4]	(7)	
To	a	mixture	of	trans-[Ir(IBioxMe4)2(COE)Cl]	(0.075	g,	0.099	mmol)	and	Na[BArF4]	(0.097	g,	0.109	mmol)	was	
added	1,2-C6H4F2	(4	mL)	under	a	H2	atmosphere	(1	atm).	The	orange	solution	was	placed	under	argon	and	
cis-cyclooctene	(0.130	mL,	0.994	mmol)	was	added.	The	solution	was	stirred	at	room	temperature	for	48	h.	
After	diluting	the	bright	orange	solution	with	heptane,	the	solution	was	filtered	and	layered	with	heptane	
to	afford	the	crude	product	on	diffusion,	which	was	then	recrystallised	from	CH2Cl2	–	heptane.	Yield	=	0.106	
g	(68%,	orange	crystals).		
	
1H	NMR	 (1,2-C6H4F2/C6D6,	400	MHz):	δ	8.11	–	8.15	 (m,	8H,	ArF),	7.50	 (br,	4H,	ArF),	4.23	 (d,	 2JHH	=	8.4,	4H,	
OCH2),	4.18	(d,	2JHH	=	8.4,	4H,	OCH2),	3.98	–	4.01	(m,	4H,	CH{COD}),	1.99	–	2.09	(m,	4H,	CH2{COD}),	1.69	(s,	
12H,	CH3),	1.60	(app	q,	J	=	8,	4H,	CH2{COD}),	1.46	(s,	12H,	CH3).	1H	NMR	(CD2Cl2,	400	MHz):	δ	7.72	–	7.73	(m,	
8H,	ArF),	7.57	(br,	4H,	ArF),	4.43	(d,	2JHH	=	8.4,	4H,	OCH2),	4.40	(d,	2JHH	=	8.4,	4H,	OCH2),	4.13	–	4.14	(m,	4H,	
CH{COD}),	2.19	–	2.22	(m,	4H,	CH2{COD}),	1.84	(s,	12H,	CH3),	1.81	(app	q,	2JHH	=	8,	4H,	CH2{COD}),	1.58	(s,	
12H,	CH3).	 13C{1H}	NMR	 (CD2Cl2,	101	MHz):	δ	162.3	 (q,	1JBC	=	50,	ArF),	155.8	 (s,	NCN),	135.4	 (s,	ArF),	129.4	
(qq,	 2JFC	=	 32,	3JBC	=	 3,	 ArF),	 127.4	 (s,	 COCH2),	 125.2	 (q,	1JFC	=	 271,	 ArF),	 118.1	 (sept,	3JFC	=	 4,	 ArF),	 88.7	 (s,	
OCH2),	74.2	 (s,	CH{COD}),	64.9	 (s,	C(CH3)2),	31.8	 (s,	CH2{COD}),	27.7	 (s,	CH3),	23.9	 (s,	CH3).	Anal.	Calcd	 for	
C62H56BF24IrN4O4	(1580.14	gmol-1):	C,	47.13;	H,	3.57;	N,	3.55.	Found:	C,	47.03;	H,	3.46;	N,	3.57.	
	
trans-[Ir(IBioxMe4)2(CO)2][BArF4]	(8)	
Route	A:	To	a	mixture	of	trans-[Ir(IBioxMe4)2(COE)Cl]	(0.0075	g,	0.010	mmol)	and	Na[BArF4]	(0.010	g,	0.011	
mmol)	was	added	1,2-C6H4F2	 (0.5	mL)	under	a	CO	atmosphere	 (1	atm).	After	4	days,	 the	orange	solution	
was	 diluted	 with	 heptane	 (0.2	 mL)	 and	 filtered.	 Layering	 the	 filtrate	 with	 heptane	 afforded	 the	 orange	
crystalline	product	on	diffusion.	Yield	=	0.011	g	(72%,	orange	crystals).		
Route	B:	A	solution	of	trans-[Ir(IBioxMe4)2(C2H4)2][BArF4]	(6;	0.030	g,	0.020	mmol)	in	1,2-C6H4F2	(0.5	mL)	was	
placed	under	a	CO	atmosphere	(1	atm).	After	2	days	stirring	at	room	temperature,	the	orange	solution	was	
placed	 under	 argon	 and	 layered	with	 heptane	 to	 afford	 the	 product	 on	 diffusion.	 Yield	 =	 0.028	 g	 (92%,	
orange	crystals).	
	
1H	NMR	(1,2-C6H4F2/C6D6,	400	MHz):	δ	8.11	–	8.17	(m,	8H,	ArF),	7.49	(br,	4H,	ArF),	4.36	(s,	8H,	OCH2),	1.71	(s,	
24H,	CH3).	1H	NMR	(CD2Cl2,	500	MHz):	δ	7.68	–	7.75	(m,	8H,	ArF),	7.56	(br,	4H,	ArF),	4.62	(s,	8H,	OCH2),	1.80	
(s,	24H,	CH3).	13C{1H}	NMR	(CD2Cl2,	126	MHz):	δ	180.6	(s,	CO),	162.3	(q,	1JBC	=	50,	ArF),	135.4	(s,	ArF),	133.4	(s,	
NCN),	129.4	(qq,	2JFC	=	32,	3JBC	=	3,	ArF),	127.7	(s,	COCH2),	125.2	(q,	1JFC	=	272,	ArF),	118.0	(sept,	3JFC	=	4,	ArF),	
88.2	(s,	OCH2),	62.3	(s,	C(CH3)2),	26.5	(s,	CH3).	Anal.	Calcd	for	C56H44BF24IrN4O6	(1527.98	gmol-1):	C,	44.02;	H,	
2.9;	N,	3.67.	Found:	C,	44.01;	H,	2.86;	N,	3.71.	IR	(CH2Cl2):	υ(CO)	=	2004	cm-1.	
	
NMR	scale	reaction	details	
trans-[Ir(IBioxMe4)2(COE)Cl]	(1)	
i. To	a	mixture	of	1	 (0.0100	g,	0.013	mmol)	and	Na[BArF4]	 (0.0065	g,	0.007	mmol)	was	added	1,2-C6H4F2	
(0.5	mL)	 in	 a	 J	 Young’s	 valve	NMR	 tube	under	 an	 atmosphere	of	H2	 (1	 atm).	 The	mixture	was	placed	
under	 argon	 and	 analysed	 by	 1H	 NMR	 spectroscopy.	 Quantitative	 formation	 of	 3	 (δIrH	 =	 -38.86)	 was	
observed	along	with	complete	hydrogenation	of	COE	to	COA	(δH	=	1.37).	
ii. To	a	mixture	of	1	 (0.0075	g,	0.010	mmol)	and	Na[BArF4]	 (0.0176	g,	0.020	mmol)	was	added	1,2-C6H4F2	
(0.5	mL)	in	a	J	Young’s	valve	NMR	tube	under	an	atmosphere	of	H2	(1	atm).	After	5	min,	the	mixture	was	
placed	under	argon	and	analysed	by	 1H	NMR	spectroscopy.	Quantitative	 formation	of	3	 (δIrH	=	 -38.85)	
was	observed	along	with	complete	hydrogenation	of	COE	to	COA	(δH	=	1.37).	
iii. To	a	mixture	of	1	 (0.0075	g,	0.010	mmol)	and	Na[BArF4]	 (0.0097	g,	0.011	mmol)	was	added	1,2-C6H4F2	
(0.5	mL)	in	a	J	Young’s	valve	NMR	tube	under	an	atmosphere	of	C2H4.	Analysis	of	the	solution	by	1H	NMR	
spectroscopy	indicated	quantitative	formation	of	6	within	15	min	at	293	K.	
iv. To	a	mixture	of	1	(0.0100	g,	0.0133	mmol)	and	Na[BArF4]	(0.0129	g,	0.0146	mmol)	in	1,2-C6H4F2	(0.5	mL)	
in	a	 J	Young’s	valve	NMR	tube	was	added	COE	(0.018	mL,	0.133	mmol).	Analysis	of	 the	solution	by	1H	
NMR	spectroscopy	indicated	the	quantitative	formation	of	7	alongside	COA	(total	1	eqv	/	Ir)	within	48h	
at	293	K	(t1/2	≈	9h	for	formation	of	7).		
	
Mixture	of	[{Ir(IBioxMe4)2(H)2}2Cl][BArF4]	(3)	and	Na[BArF4]	
Solutions	 of	 3	 and	 Na[BArF4]	 were	 prepared	 by	 placing	 a	 solution	 of	 1	 (0.010	 g,	 0.013	 mmol)	 and	
Na[BArF4]	(0.013	g,	0.015	mmol)	in	1,2-C6H4F2	(0.5	mL)	under	a	H2	atmosphere	(1	atm).	The	solution	was	
then	degassed	and	treated	as	described	below:		
i. The	mixture	of	3	and	Na[BArF4]	in	1,2-C6H4F2	prepared	as	described	above	was	placed	under	argon	and	
added	to	2,2’-bipyridine	(0.0023	g,	0.0146	mmol).	Quantitative	formation	of	4	was	observed	by	1H	NMR	
spectroscopy	within	15	min	at	293	K.	
ii. The	mixture	of	3	and	Na[BArF4]	in	1,2-C6H4F2	prepared	as	described	above	was	placed	under	argon	and	
added	 to	 IBioxMe4	 (0.0031	 g,	 0.0146	 mmol).	 After	 24	 h	 at	 293	 K,	 quantitative	 formation	 of	 5	 was	
observed	by	1H	NMR	spectroscopy.	
iii. The	mixture	of	3	and	Na[BArF4]	in	1,2-C6H4F2	prepared	as	described	above	was	placed	under	an	ethylene	
atmosphere	 (1	 atm).	 Quantitative	 formation	 of	 6	 alongside	 hydrogenation	 of	 1	 eqv	 of	 ethylene	 to	
ethane	(δC2H6	=	1.37)	was	observed	by	1H	NMR	spectroscopy	within	15	min	at	293	K.	
v. The	mixture	of	3	and	Na[BArF4]	 in	1,2-C6H4F2	prepared	as	described	above	was	placed	under	an	argon	
and	 COE	 added	 (0.018	mL,	 0.133	mmol).	 Analysis	 of	 the	 solution	 by	 1H	 NMR	 spectroscopy	 indicated	
quantitative	formation	of	7	alongside	COA	(total	3	eqv	/	Ir)	within	48	h	ar	293	K	(t1/2	≈	7h	for	formation	
of	7).		
	
[{Ir(IBioxMe4)2(H)2}2Cl][BArF4]	(3)	
i. Solution	stability	was	tested	using	a	solution	of	isolated	3	(0.0105	g,	0.0050	mmol)	in	1,2-C6H4F2	(0.5	mL)	
in	 a	 J	 Young’s	 valve	 NMR	 tube.	 No	 significant	 change	was	 observed	 after	 24	 h	 at	 293	 K,	 by	 1H	NMR	
spectroscopy.	
ii. Solution	stability	was	tested	using	a	solution	of	isolated	3	(0.0105	g,	0.0050	mmol)	in	CD2Cl2	(0.5	mL)	in	a	
J	Young’s	valve	NMR	tube.	Only	minor	decomposition	 (<	2%)	was	observed	after	24	h	at	293	K,	by	 1H	
NMR	spectroscopy.	
iii. To	a	mixture	of	isolated	3	(0.007	g,	0.0033	mmol),	Na[BArF4]	(0.003	g,	0.0036	mmol)	and	2,2’-bipyridine	
(0.0011	g,	0.0036	mmol)	was	added	1,2-C6H4F2	(0.5	mL)	in	a	J	Young’s	valve	NMR	tube.	Analysis	of	the	
red	solution	by	1H	NMR	spectroscopy	indicated	quantitative	formation	of	4	within	15	min	at	293	K.	
	
trans-[Ir(IBioxMe4)2(2,2’-bipyridyl)(H)2][BArF4]	(4)	
i. Solution	stability	was	tested	using	a	solution	of	isolated	4	(0.0163	g,	0.010	mmol)	in	1,2-C6H4F2	(0.5	mL)	
or	CD2Cl2	(0.5	mL)	in	a	J	Young’s	valve	NMR	tube.	No	significant	change	was	observed	after	24	h	at	293	K,	
by	1H	NMR	spectroscopy.	
	
[Ir(IBioxMe4)3(H)2][BArF4]	(5)	
i. Solution	stability	was	tested	using	a	solution	of	isolated	5	(0.0163	g,	0.010	mmol)	in	1,2-C6H4F2	(0.5	mL)	
or	CD2Cl2	(0.5	mL)	in	a	J	Young’s	valve	NMR	tube.	No	significant	change	was	observed	after	24	h,	at	293	
K,	by	1H	NMR	spectroscopy.	
	
trans-[Ir(IBioxMe4)2(C2H4)2][BArF4]	(6)	
i. Solution	stability	was	tested	using	a	solution	of	isolated	6	(0.0153	g,	0.010	mmol)	in	1,2-C6H4F2	(0.5	mL)	
or	CD2Cl2	(0.5	mL)	in	a	J	Young’s	valve	NMR	tube.	No	significant	change	was	observed	after	24	h	at	293	K,	
by	1H	NMR	spectroscopy.	
ii. A	solution	of	isolated	6	(0.0153	g,	0.010	mmol)	in	1,2-C6H4F2	(0.5	mL)	was	placed	under	an	atmosphere	
of	CO	(1	atm)	in	a	J	Young’s	valve	NMR	tube	and	the	ensuing	reaction	was	followed	 in	situ	by	1H	NMR	
spectroscopy.	Complex	8	was	formed	quantitatively	within	24	h	at	293	K	(t1/2	=	4	h).	
	
[Ir(IBioxMe4)2(COD)][BArF4]	(7)	
i. Solution	stability	was	tested	using	a	solution	of	isolated	7	(0.0158	g,	0.010	mmol)	in	1,2-C6H4F2	(0.5	mL)	
or	CD2Cl2	 (0.5	mL)	 in	a	 J	Young’s	valve	NMR	tube.	No	change	was	observed	after	24	h	at	293	K,	by	1H	
NMR	spectroscopy.	
ii. A	solution	of	isolated	7	(0.0079	g,	0.0050	mmol)	in	1,2-C6H4F2	(0.5	mL)	was	placed	under	an	atmosphere	
of	CO	(1	atm)	in	a	J	Young’s	valve	NMR	tube	and	the	ensuing	reaction	was	followed	 in	situ	by	1H	NMR	
spectroscopy.	Complex	8	was	formed	quantitatively	within	14	days	at	293	K	(t1/2	=	77	h).	
	
Computational	details	
Geometry	 optimisations	 without	 symmetry	 constraints	 (except	 for	 6b’,	 as	 indicated)21	 were	 carried	 out	
using	the	Gaussian0926	optimiser	(standard	convergence	criteria)	combined	with	Turbomole	(version	6.5)27	
energies	and	gradients	 (SCF	convergence	criterion	10-8	a.u.,	grid	m4).	Density	 functional	 theory	was	used	
with	the	GGA	functional	BP8628,	the	def2-TZVPP29	basis	set	and	considering	dispersion	corrections	with	the	
DFT-D3	scheme.30	Character	of	stationary	points	as	minima	on	the	potential	energy	surface	was	verified	by	
computation	 of	 the	Hessian	matrix.	 To	 shed	 light	 on	 the	 bonding	 situation	 in	 the	molecules,	 the	 Energy	
Decomposition	Analysis	 (EDA)31	with	Natural	Orbitals	 for	Chemical	Valence	 (EDA-NOCV)32	was	carried	out	
on	 the	 structures	without	 reoptimisation	 (PBE33/TZ2P	 plus	DFT-D3)	 using	 the	 ADF	 2013	 package.34	More	
details	regarding	the	EDA	and	EDA-NOCV	can	be	found	in	the	literature.35	
	
Supporting	information	
Selected	NMR	 spectra	 and	 additional	 computational	 details	 including	 Table	 S1	 and	 Figures	 S13,	 S14	 and	
S15;	optimized	geometries	in	Cartesian	coordinates	and	SCF	energies	(BP86-D3/def-TZVPP)	in	a.u.	for	6,	6’,	
6a’	 and	 6b’	 (.xyz).	 This	 material	 is	 available	 free	 of	 charge	 via	 the	 Internet	 at	 http://pubs.acs.org.	 Full	
crystallographic	details	including	solution,	refinement	and	disorder	modelling	procedures	are	documented	
in	 CIF	 format	 and	 have	 been	 deposited	 with	 the	 Cambridge	 Crystallographic	 Data	 Centre	 under	 CCDC	
1415792	–	1415797.	These	data	can	be	obtained	free	of	charge	from	The	Cambridge	Crystallographic	Data	
Centre	via	www.ccdc.cam.ac.uk/data_request/cif.	
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